Conrad Hal Waddington: the last Renaissance biologist? ,
Epigenetics: A Landscape Takes Shape, Cell, vol.456, issue.4, pp.635-638, 2007. ,
The molecular hallmarks of epigenetic control, Nat. Rev. Genet, vol.458, issue.8, pp.487-500, 2016. ,
Epigenomics-Guided Drug Development: Recent Advances in Solving the 460 Cancer Treatment "jigsaw puzzle, OMICS, vol.23, issue.2, pp.70-85, 2019. ,
Epigenetic drugs: More than meets the eye, undefined, vol.12, issue.5, p.462, 2017. ,
Function and information content of DNA methylation, Nature, vol.464, issue.7534, pp.321-326, 2015. ,
Charting histone modifications and the functional 466 organization of mammalian genomes, Nat. Rev. Genet, vol.12, issue.1, pp.7-18, 2011. ,
Chromatin Modifications and Their Function, Cell, vol.128, issue.4, p.468, 2007. ,
The roles of DNA, RNA and histone 470 methylation in ageing and cancer, Nat. Rev. Mol. Cell Biol, vol.150, issue.6, pp.12-17, 2019. ,
The functions of animal microRNAs, Nature, vol.431, issue.7006, pp.350-355, 2004. ,
, Long Non-Coding, vol.473
, RNAs in the Regulation of Gene Expression: Physiology and Disease. Noncoding RNA, vol.474, issue.1, p.17, 2019.
Epigenetic regulation during 476 the differentiation of stem cells to germ cells, Oncotarget, vol.8, issue.34, p.477, 2017. ,
Epigenetics: The master 479 control of endothelial cell fate in cancer, Life Sciences, vol.232, p.116652, 2019. ,
Roles and regulation of histone methylation in animal 481 development, Nat. Rev. Mol. Cell Biol, vol.403, pp.1-17, 2019. ,
Genetic alterations and epigenetic alterations of cancer-associated 483 fibroblasts, Oncol Lett, vol.13, issue.1, pp.3-12, 2017. ,
Understanding the epigenetic regulation of 485 tumours and their microenvironments: opportunities and problems for epigenetic 486 therapy, J. Pathol, vol.241, issue.1, pp.10-24, 2017. ,
This review underlines the impact of epigenetic control on the tumor 488 microenvironment and in particular myeloid compartment ,
Epigenetic control of the tumor 490 microenvironment, vol.8, p.491, 2016. ,
Enduring epigenetic landmarks define the 493 cancer microenvironment, Genome Res, vol.28, issue.5, pp.625-638, 2018. ,
Cancer Genetics and Epigenetics: Two Sides of the Same Coin? 495 Cancer Cell, vol.22, pp.9-20, 2012. ,
Loss of the HVEM Tumor Suppressor in 497 Lymphoma and Restoration by Modified CAR-T Cells, Cell, vol.167, issue.2, p.498, 2016. ,
Molecular pathogenesis of germinal center-derived B cell lymphomas, Immunological Reviews, vol.500, issue.1, pp.240-261, 2019. ,
Chromatin modifying gene mutations in follicular lymphoma, Blood, vol.502, issue.6, pp.595-604, 2018. ,
Genetic Hierarchy of Acute Myeloid 504 Leukemia: From Clonal Hematopoiesis to Molecular Residual Disease, International 505 Journal of Molecular Sciences, vol.19, issue.12, p.3850, 2018. ,
Cancer-epigenetics comes of age, Nature Genetics, vol.21, issue.2, pp.163-507, 1999. ,
, The Epigenomics of Cancer. Cell, vol.128, issue.4, pp.683-692, 2007.
, H3K27 Demethylase JMJD3 Employs the 510 NF-?B and BMP Signaling Pathways to Modulate the Tumor Microenvironment and 511
, Promote Melanoma Progression and Metastasis, Cancer Res, vol.76, issue.1, pp.161-170, 2016.
Accessories to the Crime: Functions of Cells Recruited to 513 the Tumor Microenvironment, Cancer Cell, vol.21, issue.3, pp.309-322, 2012. ,
Tumor Microenvironment and Differential Responses to Therapy. 515 Cold Spring Harb Perspect Med, vol.7, p.26781, 2017. ,
The Role of Tumor Microenvironment in 517 Chemoresistance: 3D Extracellular Matrices as Accomplices, International Journal of 518 Molecular Sciences, vol.19, issue.10, p.2861, 2018. ,
The Role of Tumor Microenvironment 520 in Chemoresistance: To Survive, Keep Your Enemies Closer, International Journal, vol.521, p.58 ,
Methylation determines fibroblast 602 activation and fibrogenesis in the kidney, Nat. Med, vol.16, issue.5, pp.544-550, 2010. ,
Stromal epigenetic alterations drive metabolic 604 and neuroendocrine prostate cancer reprogramming, J. Clin. Invest, vol.128, issue.10, p.4484, 2018. ,
The DNA methyl-607 transferase protein DNMT1 enhances tumor-promoting properties of breast stromal 608 fibroblasts, Oncotarget, vol.9, issue.2, pp.2329-2343, 2018. ,
Histone deacetylase 6 regulates the immunosuppressive 610 properties of cancer-associated fibroblasts in breast cancer through the STAT3-611 COX2-dependent pathway, Oncogene, vol.37, issue.45, pp.5952-5966, 2018. ,
Epigenetic interplay between 613 immune, stromal and cancer cells in the tumor microenvironment, Clinical 614 Immunology, vol.196, pp.64-71, 2018. ,
Suppression of TGF?-mediated conversion of 616 endothelial cells and fibroblasts into cancer associated (myo)fibroblasts via HDAC 617 inhibition, British Journal of Cancer, vol.118, issue.10, pp.1359-1368, 2018. ,
Cancer-Associated Fibroblasts Neutralize 619 the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration 620 of Tumors, Cancer Cell, vol.32, issue.5, 2017. ,
Convergent roles of ATF3 and CSL in 622 chromatin control of cancer-associated fibroblast activation, J. Exp. Med, vol.214, issue.8, pp.2349-2368, 2017. ,
Cancer cell niche factors secreted from cancer-625 associated fibroblast by loss of H3K27me3, Gut. gutjnl, 2018. ,
Stromal epigenetic dysregulation is 627 sufficient to initiate mouse prostate cancer via paracrine Wnt signaling, Proc. Natl ,
Cancer-associated fibroblasts enhance the migration 630 ability of ovarian cancer cells by increasing EZH2 expression, International Journal, p.631 ,
, Molecular Medicine, vol.33, issue.1, pp.91-96, 2014.
Normal stroma suppresses cancer cell 633 proliferation via mechanosensitive regulation of JMJD1a-mediated transcription. 634, Nature Communications, vol.7, issue.1, p.12237, 2016. ,
Dysregulation of miRNA Expression in Cancer 636 Associated Fibroblasts (CAFs) and Its Consequences on the Tumor 637 Microenvironment, Cancers (Basel), vol.9, issue.6, p.54, 2017. ,
Control of tumor and microenvironment 639 cross-talk by miR-15a and miR-16 in prostate cancer, Oncogene, vol.30, issue.41, p.640, 2011. ,
Stromal fibroblast-derived miR-409 promotes 642 epithelial-to-mesenchymal transition and prostate tumorigenesis, Oncogene, vol.34, issue.21, pp.2690-2699, 2015. ,
Regulation of miR-645 200c/141 expression by intergenic DNA-looping and transcriptional read-through. 646, Nature Communications, vol.7, issue.1, p.8959, 2016. ,
Regulatory T cells in cancer immunosuppression 648 -implications for anticancer therapy, Nature Reviews Clinical Oncology, vol.155, p.1, 2019. ,
,
, Myeloid-derived suppressor cells and tumor: Current knowledge and future 652 perspectives, J. Cell. Physiol, vol.117, issue.1, p.7021, 2018.
Epigenetics in myeloid derived suppressor cells: a 654 sheathed sword towards cancer, Oncotarget, vol.7, issue.35, pp.57452-57463, 2016. ,
Generation and functional 656 characterization of MDSC-like cells, Oncoimmunology, vol.6, issue.4, p.1295203, 2017. ,
Epigenetic Regulation of Foxp3 Expression in 658 ,
, Regulatory T Cells by DNA Methylation. The Journal of Immunology, vol.182, issue.1, p.659, 2009.
Prostaglandin E2 Leads to the 661 Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-662 Derived Suppressor Cells, Cell Reports, vol.21, issue.1, pp.154-167, 2017. ,
?9-Tetrahydrocannabinol-mediated 664 epigenetic modifications elicit myeloid-derived suppressor cell activation via 665 STAT3/S100A8, J. Leukoc. Biol, vol.97, issue.4, pp.677-688, 2015. ,
??-Tetrahydrocannabinol attenuates 667 allogeneic host-versus-graft response and delays skin graft rejection through 668 activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor 669 cells, J. Leukoc. Biol, vol.98, issue.3, pp.435-447, 2015. ,
Histone deacetylase 11: A novel epigenetic 671 regulator of myeloid derived suppressor cell expansion and function, Mol. Immunol, vol.672, issue.2, pp.579-585, 2015. ,
Epigenetic silencing of retinoblastoma gene 674 regulates pathologic differentiation of myeloid cells in cancer, Nat. Immunol, vol.14, issue.3, pp.211-220, 2013. ,
, Activates iNOS Expression in, p.677
, Myeloid-Derived Suppressor Cells, Cancer Res, vol.77, issue.11, pp.2834-2843, 2017.
Epigenetic silencing of TH1-type chemokines 679 shapes tumour immunity and immunotherapy, Nature, vol.527, issue.7577, pp.249-253, 2015. ,
, * The epigenetic silencing of EZH2 and DNA methylation in TH1 cells allow re-681 expression of CXCL9 and CXCL10 and reduce tumor immunosuppression, vol.682, p.86
, , vol.683
, Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer, Cancer Res, vol.684, issue.2, pp.275-282, 2016.
Glioma exosomes mediate the expansion and function 686 of myeloid-derived suppressor cells through microRNA-29a/Hbp1 and microRNA-687 92a/Prkar1a pathways, International Journal of Cancer. ijc, p.32052, 2018. ,
Immunosuppressive effects of hypoxia-induced glioma 689 exosomes through myeloid-derived suppressor cells via the miR-10a/ Rora ,
, / Pten Pathways. Oncogene, vol.37, issue.31, pp.4239-4259, 2018.
Tumor-derived microRNAs induce myeloid 692 suppressor cells and predict immunotherapy resistance in melanoma, J. Clin. Invest, vol.693, issue.12, pp.5505-5516, 2018. ,
Exosomes Released from Tumor-Associated Macrophages 695 Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian 696 Cancer, Cancer Immunol Res, vol.6, issue.12, pp.1578-1592, 2018. ,
Epigenetic therapy of cancer: past, present and future, Nature 698 Reviews Drug Discovery, vol.5, issue.1, pp.37-50, 2006. ,
Targeting Cancer with Epi-Drugs: A 700 Precision Medicine Perspective, Curr Pharm Biotechnol, vol.17, issue.10, pp.856-865, 2016. ,
Targeting DNA Methylation, Clin Cancer Res, vol.15, issue.12, pp.3938-702, 2009. ,
, DNA-Demethylating Agents Target, vol.704
, Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts, Cell. 705, vol.162, issue.5, pp.961-973, 2015.
This study demonstrated the decreasing of colorectal cancers cells proliferation by 707 DNA-demethylating agents which induce a viral mimicry response, vol.708, p.95 ,
Inhibiting DNA Methylation Causes an 709 ,
, Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses, Cell, vol.710, issue.5, pp.974-986, 2015.
The immunomodulatory anticancer agent, RRx-001, 712 induces an interferon response through epigenetic induction of viral mimicry, Clin 713 Epigenetics, vol.9, issue.1, p.4, 2017. ,
, Novo Epigenetic Programs Inhibit PD, issue.1
, Blockade-Mediated T Cell Rejuvenation. Cell, vol.170, issue.1, 2017.
DNA methyltransferase inhibition increases 717 efficacy of adoptive cellular immunotherapy of murine breast cancer, Cancer 718 Immunol. Immunother, vol.65, issue.9, pp.1061-1073, 2016. ,
DNA demethylating agent 5-azacytidine 720 inhibits myeloid-derived suppressor cells induced by tumor growth and 721 cyclophosphamide treatment, J. Leukoc. Biol, vol.95, issue.5, pp.743-753, 2014. ,
Stromal remodeling by the BET bromodomain 723 inhibitor JQ1 suppresses the progression of human pancreatic cancer, Oncotarget, vol.724, issue.7, pp.61469-61484, 2016. ,
Abrogation of myofibroblast activities in 726 metastasis and fibrosis by methyltransferase inhibition, International Journal of 727 Cancer, vol.19, p.1423, 2019. ,
Epigenetic therapy activates type I interferon 729 signaling in murine ovarian cancer to reduce immunosuppression and tumor 730 burden, Proc. Natl. Acad. Sci. U.S.A, vol.114, issue.51, pp.10981-10990, 2017. ,
Modulation of EZH2 expression in T cells 732 improves efficacy of anti-CTLA-4 therapy, J. Clin. Invest, vol.128, issue.9, pp.3813-3818, 2018. ,
Entinostat Converts Immune-Resistant 734 Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by 735 Reprogramming Tumor-Infiltrating MDSCs, Cancer Immunol Res, vol.6, issue.12, pp.1561-1577, 2018. ,
The class I/IV HDAC inhibitor mocetinostat 738 increases tumor antigen presentation, decreases immune suppressive cell types and 739 augments checkpoint inhibitor therapy, Cancer Immunol. Immunother, vol.67, issue.3, p.392, 2018. ,
DNA methyltransferase inhibition accelerates the 742 immunomodulation and migration of human mesenchymal stem cells, Sci Rep, vol.5, p.8020, 2015. ,
EZH2 inhibitor GSK126 suppresses anti-tumor 745 immunity by driving production of myeloid-derived suppressor cells, Cancer Res. 746 canres.2395, 2018. ,
Histone 748 deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid-derived 749 suppressor cells in vitro and in vivo, J. Leukoc. Biol, vol.91, issue.5, pp.701-709, 2012. ,
Editorial: HDAC inhibition begets more MDSCs, J. Leukoc. Biol, vol.91, issue.5, p.681, 2012. ,
Deacetylase inhibition promotes the 753 generation and function of regulatory T cells, Nat. Med, vol.13, issue.11, pp.1299-1307, 2007. ,
Trichostatin A promotes the generation and 755 suppressive functions of regulatory T cells, Clin. Dev. Immunol, vol.2013, issue.67, pp.679804-679812, 2013. ,
Histone/protein deacetylase inhibitors increase 758 suppressive functions of human FOXP3+ Tregs, Clin. Immunol, vol.136, issue.3, pp.348-363, 2010. ,
Histone deacetylase inhibitors provoke a tumor 761 supportive phenotype in pancreatic cancer associated fibroblasts, Oncotarget, vol.8, issue.12, pp.19074-19088, 2017. ,
Chromatin 764 remodeling underlies the senescence-associated secretory phenotype of tumor 765 stromal fibroblasts that supports cancer progression, Cancer Res, vol.72, issue.9, pp.2251-2261, 2012. ,
Advancements in the delivery of epigenetic 768 drugs, Expert Opinion on Drug Delivery, vol.12, issue.9, pp.1501-1512, 2015. ,
Strategies of targeting pathological stroma for 770 enhanced antitumor therapies, Pharmacological Research, vol.148, p.104401, 2019. ,
Single-cell epigenomics: techniques and emerging 772 applications, Nat. Rev. Genet, vol.16, issue.12, pp.716-726, 2015. ,
Simultaneous profiling of 3D genome structure and DNA 774 methylation in single human cells, Nat. Methods, vol.62, issue.10, pp.1-8, 2019. ,
Single-cell epigenomics: Recording the past and 776 predicting the future, Science, vol.358, issue.6359, pp.69-75, 2017. ,